Prof Keith Barton

Consultant Ophthalmologist and Director of The Glaucoma Service, Moorfields Eye Hospital, London, UK

Keith’s principal interests are the surgical management of glaucoma (especially with aqueous shunt devices and MIGS approaches) and secondary glaucomas – Keith runs an NHS clinic at Moorfields that’s uniquely dedicated to the management of glaucoma in uveitis. However, Keith’s skillset goes beyond surgery. He’s well known for organising and running glaucoma educational symposia that have attracted significant acclaim, and he famously co-founded and organized (with Kuldev Singh [qv]) the Ophthalmology Futures Forum investor networking events that take place in both Europe and Asia.

Prof Bart P. Leroy

Bart P. Leroy, MD, PhD, is director of the Ophthalmic Genetics and Retinal Degenerations clinics in the Division of Ophthalmology and Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia.

Prof. Leroy is a professor of Ophthalmic Genetics and Visual Electrophysiology at Ghent University as well as head of Department of Ophthalmology, Ghent University Hospital.

Prof. Leroy also serve as the director of the Ophthalmic Genetics and Retinal Degenerations clinics at The Children's Hospital of Philadelphia. His clinical focus is diagnosis and treatment of patients with inherited retinal and eye diseases including Leber congenital amaurosis, Stargardt disease, retinitis pigmentosa, and various other genetic syndromes and anomalies. In collaboration with the team of Drs. Jean Bennett, Albert M. Maguire and Katherine High, Prof. Leroy is involved in the ongoing gene therapy research work for inherited retinal blindness here at CHOP.

Prof. Leroy is past president for the European Organization for Vision & Eye Research, as well as a member of the International Society for Genetic Eye Disease & Retinoblastoma, the Société de la Génétique Ophtalmologique Francophone and the Academia Ophthalmologica Belgica.

Prof Carlos Pavesio

Consultant Ophthalmologist, Director of Medical Retina Service, Moorfields Eye Hospital, London, UK

Prof Carlos Pavesio is ex-Director and a Consultant Ophthalmic Surgeon for the Medical Retinal Service at Moorfields Eye Hospital, London, UK. He is also the uveitis theme leader for the Biomedical Research Centre, Institute of Ophthalmology, London. He obtained his medical degree from Paulista School of Medicine in Sao Paulo, Brazil, where he stayed as a resident and completed his doctoral studies in Ophthalmology in 1991. He also undertook a fellowship in Ocular Inflammation at the Proctor Foundation in San Francisco and fellowships in External Diseases and Uveitis at Moorfields Eye Hospital. Mr Pavesio is a member of a number of international and regional ophthalmological societies, including the Association for Research in Vision and Ophthalmology, the British Uveitis Group, and the American Academy of Ophthalmology. His professional interests focus on the treatment and management of ocular inflammatory diseases including uveitis, scleritis, ocular infections and cataracts. Mr Pavesio is the Editor-in-Chief for the Journal of Ophthalmic Inflammation and Infection and a member of the editorial board of the British Journal of Ophthalmology, Ocular Immunology and Inflammation, International Ophthalmology, and Journal of Ocular Infections and Inflammation and Ophthalmology. He has authored more than 10 book chapters and over 120 research publications in the field. He has also been editor for three books in ophthalmology.

Prof Alan Bird

Emeritus Professor and Consultant at the Institute of Ophthalmology at the Moorfields Eye Hospital, London

Best known for his work on retinitis pigmentosa and research into inherited retinal degeneration, Prof Bird studied neurology and neurosurgery, but later turned to ophthalmology. While at the Institute of Ophthalmology, he worked with numerous fellows in a variety of multidisciplinary activities involving electrophysiology, specialized imaging, psychophysics, immunology, and pathology – which resulted in the development of new technologies to define the clinical characteristics of retinal disease. His studies have also correlated abnormal gene expression with metabolic dysfunction at the cellular level, which has led to a clearer understanding of retinal degenerative diseases, and has had significant implications for clinical management of these disorders, including better genetic counseling for patients and the development of new treatment approaches, including gene therapy. He has received many awards, including the Duke Elder, Doyne and Bowman medals and the Prix Chauvin, and the Helen Keller Prize for Vision Research. Prof Bird has undertaken extensive international work: in Africa tackling river blindness, and in Jamaica, examining the retinal changes that occur in patients with sickle cell disease.

Prof Suber S. Huang

CEO of the Retina Center of Ohio and Voluntary Assistant Clinical Professor of Ophthalmology at Bascom Palmer Eye Institute, University of Miami

Suber S. Huang, MD, MBA is committed to clinical excellence, innovative research, and world-wide education. Dr. Huang is currently CEO of the Retina Center of Ohio and Voluntary Assistant Clinical Professor of Ophthalmology at Bascom Palmer Eye Institute, University of Miami. Dr. Huang is Chair, NEI/NIH National Eye Health Education Program and is the AAO representative to the United States Pharmacopeia (USP). He is the former AAO Associate Secretariat of Federal Affairs; Chair, Research, Regulatory, and External Scientific Affairs Committee; and Chair, Compounding Pharmacy taskforce, and is the current AAO representative to the USP. He founded the Retina Image Bank, now the world’s largest and most comprehensive open-access multimedia database of “all things retina”. With over 40,000 images contributed, imagebank.asrs.org links expertise around the world and, in 2019, will exceed 2 million cumulative page-views. The Retina Image Bank has been used in 194 countries representing 99.2% of the world’s population. He is an editor for the APJO and APAO Chair, Retina Vitreous on-line education. He is a founding officer of Retina Global, bioscience advisor to the Anderson Scholars program and Life Trustee at the University School. He is editor-in-chief of the ASRS Retina Atlas with expected completion in 2020. He is President/CEO of The Future Vision Foundation, FutureVisionFound.org, whose mission celebrates breakthrough vision research through powerful documentaries of discovery, impact, and hope.

From 1993-2014, Dr. Huang’s leadership positions in the CWRU Department of Ophthalmology and Visual Sciences include: Philip and Elizabeth Searle – Suber Huang MD Professor and Vice-Chair, Residency Program Director, and Director, Center for Retina and Macular Disease. He founded the Retina Diseases Image Analysis Reading Center and was Director of the Visual Sciences Research Center.

He received his undergraduate degree at Johns Hopkins University, medical degree from the Albert Einstein College of Medicine, ophthalmology residency at the Wilmer Eye Institute/Johns Hopkins University and fellowship in Vitreoretinal Diseases and Surgery from Bascom Palmer Eye Institute (BPEI)/University of Miami. He has graduate training at the Harvard University, Wharton School of Business/University of Pennsylvania, and received his Executive MBA from the Weatherhead School of Management/Case Western Reserve University (CWRU).

Dr. Huang has participated in numerous clinical trials as PI and as Director of the Retina Disease Image Analysis Reading Center at CWRU. He has published widely, given nearly 400 lectures, and has served as Program Chair for retina surgery for the APAO and AAO retina sub-specialty day. He is the IMSM for the Argus II retina prosthesis programs, Chair of the DMC for on-going gene therapy trials for NVAMD, for stem cell transplant trials in atrophic AMD, and the world’s largest trial of triple therapy for onchocerchiasis and lymphatic filariasis. He has active research interests in surgical innovation, gene therapy, the immunoregulatory properties of stem cells, and epigenomics.

Dr. Huang has received the “Top Doctors” and “Best Doctors in America” award each year since 2003, the AAO Secretariat Award (twice), and the AAO and ASRS Senior Achievement and Honor Awards. Other awards include the Rainbow Babies and Children’s Hospital Pediatric Innovation, OPS J. Donald M. Gass MD award, International Congress of Ophthalmic Photographers, the National Diversity Council Leadership Excellence Award, and the Cleveland Sight Center Person of the Year. He has received the CWRU Department of Ophthalmology Attending of the Year and cherishes the CWRU Humanism in Medicine award given annually to the School of Medicine faculty member who most demonstrates compassion and professionalism in the care of patients and their families.

In 2017, Dr. Huang was inducted to the Retina Hall of Fame and produced Seven Years of Darkness, which won the best short documentary at the national short film festival. In 2018, Dr. Huang received the Jose Rizal International Medal from the Asia-Pacific Academy of Ophthalmology, their highest recognition for contributions to education and clinical care.

Prof Jonathan Guy Crowston

Senior Consultant Glaucoma, Singapore National Eye Centre

Prof Crowston is a Professor of Ophthalmology in the Neuroscience and Behavioural Disorders programme at Duke-NUS Medical School, and a glaucoma consultant at the Singapore National Eye Centre. His research focuses on understanding why ageing predisposes individuals to optic nerve damage in glaucoma, and developing new therapeutic approaches to boost neuronal repair.

He obtained his medical degree at the Royal Free Hospital SOM, London, and a PhD at University College London. Following ophthalmology training at Moorfields Eye Hospital, he completed glaucoma fellowships at Westmead Hospital in Sydney and the University of California, San Diego. He was subsequently appointed as a faculty member in the University of California, San Diego, and served as Director of the Hamilton Glaucoma Center Basic Research Laboratories. He moved to Melbourne in July 2006 and established the Glaucoma Research Laboratory at the Centre for Eye Research Australia (CERA). He was subsequently appointed as Head of Ophthalmology at the University of Melbourne and Director of CERA.

Professor Sir Peng Tee Khaw

Professor and Consultant Ophthalmic Surgeon at Moorfields Eye Hospital and UCL Institute of Ophthalmology, Director or the UK NIHR Biomedical Research Centre in Ophthalmology, London, UK

He is Professor of Glaucoma and Ocular Healing, and Consultant Ophthalmic Surgeon at Moorfields Eye Hospital and UCL Institute of Ophthalmology.

His numerous achievements include, among others, groundbreaking studies on the modulation of the healing response after glaucoma surgery, techniques to improve the safety of trabeculectomy and continued caring for difficult paediatric patients.

An unstoppably passionate advocate for eye and vision research, he was able to raise large sums for research programmes and new clinical facilities, including the largest children’s eye hospital in the world, named after one of his patients.

Internationally, he was a member of the Board of Trustees of ARVO in 2008/2013, and in 2012/3 he served as President, the first ever UK-based ARVO president; in 2013 he was elected to the Board of Governors of the World Glaucoma Association.

Prof Paul Chew

Professor and Senior Consultant at the Department of Ophthalmology National University Hospital and National University of Singapore

Prof Paul Chew is an eye surgeon and professor in National University of Singapore, who is working on glaucoma problems.

At present, he has made new inventions in laser therapy for glaucoma and implants for advanced glaucoma disease.

His insights from many years of treating glaucoma patients has focussed the therapies he designs to fill the gaps in current day glaucoma therapy and to innovate new solutions to help control glaucoma disease and vision loss.

His early work on angle closure glaucoma laser treatment led him to newer laser therapies and to the current view of making complete and coordinated treatments for glaucoma management that both increase successful control and improve a patients quality of life while living with glaucoma.

Prof Chew remains directed to making effective solutions to improving glaucoma patient outcomes and treatments with better acceptability to patients in terms of daily living.

Prof Chew currently works as a Professor and Senior Consultant at the Department of Ophthalmology National University Hospital and National University of Singapore.

A/Prof Mohammad Javed Ali

HEAD, Govindram Seksaria Institute of Dacryology, Hyderabad
Visiting Professor, Friedrich-Alexander University, Nuremberg, Germany.
Adjunct Associate Professor of Ophthalmology, University of Rochester, New York
Senior Von Humboldt Scientist, FAU, Nuremberg, Germany

Mohammad Javed Ali is an internationally recognized oculoplastic surgeon specializing in state of art lacrimal surgeries and is a leader in advances of the lacrimal drainage sciences. He currently heads the Govindram Seksaria Institute of Dacryology and is the Alumni Chair of Ophthalmology at the L.V. Prasad Eye Institute, India. Javed is also currently the Editor in Chief of the journal 'Seminars in Ophthalmology', Hong Leong Professor at the National University of Singapore and DAAD Professor of Ophthalmology and Anatomy at the Friedrich Alexander Universtiy, Nuremberg. He completed his basic medical education and MS Ophthalmology from NTR University of Health Sciences, Hyderabad. He obtained his fellowship of Royal College of General Practitioners (FRCGP), UK in 2003 and fellowship of Royal College of Physicians and Surgeons of Glasgow (FRCS) in 2008. He also completed his fellowship in Orbital Surgery in 2008, followed by a second fellowship in Ophthalmic Plastic Surgery and Ocular Oncology and Aesthetic Facial Plastic Surgery in 2010. He later trained in Rhinology with World leader Peter-John Wormald from Australia. Javed is one among the rare recipients of The Experienced Researcher – Senior Alexander Von Humboldt Fellowship Award, one of the pinnacle awards in the Research World. He completed his working PhD on ‘glycobiology of lacrimal drainage system’ in 2018 from University of Hyderabad. He is a recipient of the Shanti Swarup Bhatnagar Prize, the Indian Nobel Prize and also the highest scientific award by the Government of India. He also received Dr P Siva Reddy Gold Medal in Ophthalmology, Dr Pathak Medal in Ophthalmology, Mazher Foundation Award for outstanding academic performance, Vengal Rao Medal, Raghavachary medal, Ranga Reddy Endowment award, FTCCI CAR award, Honavar award and Sunayna Medal. He described 3 new diseases of the lacrimal system along with their classifications and clinicopathologic profiles. He was honored by the 2015 ASOPRS Merrill Reeh Award for his path-breaking work on 'etiopathogenesis of punctal stenosis', and with 2020 ASOPRS 'Lester T Jones Award', for his outstanding scientific contributions to Dacryology. His textbook “Principles and Practice of Lacrimal Surgery” is considered to be the most comprehensive treatise on the subject and his other treatise ‘Atlas of Lacrimal Drainage Disorders’, is the first of its kind. He is a section editor for 13 journals, associate editor of Survey of Ophthalmology and a reviewer for 30+ major journals. His areas of research are molecular pathogenesis of primary acquired nasolacrimal duct obstruction, molecular anatomy of the lacrimal drainage pathways, and minimally invasive endoscopic lacrimal surgeries.

He has to his credit 473 publications at the time of this writing and has delivered 323 conference lectures including 12 keynote addresses. He has conducted 25 instruction courses and 30 live surgical workshops and has been honored by 35 national and international awards.

Prof Prem Subramanian

Chief, Neuro-Ophthalmology
Department of Ophthalmology
University of Colorado School of Medicine

Prem S. Subramanian is the Professor of ophthalmology, neurology, and neurosurgery at University of Colorado School of Medicine Anschutz Medical Campus. He specializes in neuro-ophthalmology, with special interest in the treatment of thyroid eye disease, disorders that cause double-vision in adults, as well as orbital and skull base tumors. His clinical practice includes patients with all types of disorders of the optic nerve and orbit. He performs surgery for tumors of the orbit, thyroid exophthalmos, and strabismus.

Dr. Subramanian received his medical degree from Baylor College of Medicine, Houston, Texas followed by residency in ophthalmology from Walter Reed Army Medical Center, Washington, DC and fellowship in neuro-ophthalmology from Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. He has an experience in treating conditions like cranial nerve palsies, double vision, intracranial hypertension, multiple sclerosis, ophthalmology, optic nerve disease, orbital tumors, pseudotumor cerebri, skull base tumors, strabismus, thyroid eye disease, and venous sinus stenosis. His research interests include optic nerve regeneration, traumatic brain injury, and effects of diplopia on quality of life.